T1	Participants 35 101	clomiphene citrate-resistant women with polycystic ovary syndrome.
T2	Participants 263 341	women with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS).
T3	Participants 350 414	Thirty-seven women with CC-resistant PCOS were randomly assigned
T4	Participants 1445 1474	women with CC-resistant PCOS.
